Cary Vance Buys 10,022 Shares of AVITA Medical (ASX:AVH) Stock

AVITA Medical, Inc. (ASX:AVH) insider Cary Vance bought 10,022 shares of the company’s stock in a transaction on Thursday, January 22nd. The stock was bought at an average price of A$1.17 per share, with a total value of A$11,675.63.

AVITA Medical Stock Performance

The company has a current ratio of 8.18, a quick ratio of 9.32 and a debt-to-equity ratio of 0.36. The stock has a market cap of $226.55 million, a price-to-earnings ratio of -5.55 and a beta of 1.54.

AVITA Medical Company Profile

AVITA Medical, Inc, together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc AVITA Medical, Inc was incorporated in 2020 and is headquartered in Valencia, California.